ARCHIVES

Two Regorafenib Trials Demonstrate Efficacy, Improve Overall and Progression-Free Survival

This article is from The Cancer Letter archive.

Vol. 35 No. 12 | December 28, 2012

Download PDF Visit The Full Archive

Related Articles

In Brief: Michael Grever Named DCT Deputy Director; MSK’s Burton Lee New White House Physician

March 31, 1989

ACS Reports Breast Cancer Incidence At All Time High

January 23, 1987

DHEA- Sulfate Said To Prevent Breast Cancer, Overweight

March 28, 1980

IMRT Usage and Cost Related to Geography And Medicare Reimbursement Policy, Study Finds

April 29, 2011

Sharfstein To Leave FDA

January 7, 2011

NTP Board Okays concept for New In Vitro study Using Oncogenes

May 10, 1985